Cargando…

Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients

BACKGROUND: CD4(+) T cells are of great importance in the pathogenesis of systemic lupus erythematosus (SLE), as an imbalance between CD4(+) regulatory T cells (Tregs) and CD4(+) responder T cells (Tresps) causes flares of active disease in SLE patients. In this study, we aimed to find the role of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaier, Matthias, Gottschalk, Claudius, Uhlmann, Lorenz, Speer, Claudius, Kälble, Florian, Eckstein, Volker, Müller-Tidow, Carsten, Meuer, Stefan, Mahnke, Karsten, Lorenz, Hanns-Martin, Zeier, Martin, Steinborn, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299578/ https://www.ncbi.nlm.nih.gov/pubmed/30563559 http://dx.doi.org/10.1186/s13075-018-1778-6

Ejemplares similares

Impaired Differentiation of Highly Proliferative ICOS(+)-Tregs Is Involved in the Transition from Low to High Disease Activity in Systemic Lupus Erythematosus (SLE) Patients
por: Kälble, Florian, et al.
Publicado: (2021)

Chronic Kidney Failure Provokes the Enrichment of Terminally Differentiated CD8(+) T Cells, Impairing Cytotoxic Mechanisms After Kidney Transplantation
por: Leonhard, Jonas, et al.
Publicado: (2022)

Exhaustion of CD8(+) central memory responder T cell differentiation provokes non-melanoma skin cancer in elderly kidney transplant recipients
por: Leonhard, Jonas, et al.
Publicado: (2023)

Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis
por: Speer, Claudius, et al.
Publicado: (2020)

Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study
por: Speer, Claudius, et al.
Publicado: (2021)

BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study
por: Speer, Claudius, et al.
Publicado: (2023)

Membranous nephropathy followed by anti-glomerular basement disease: A case report and review of clinical presentation and treatment
por: Speer, Claudius, et al.
Publicado: (2018)

DR(high+)CD45RA(−)-Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients
por: Schaier, Matthias, et al.
Publicado: (2012)

Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy
por: Töllner, Maximilian, et al.
Publicado: (2022)

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
por: Speer, Claudius, et al.
Publicado: (2021)

Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks
por: Speer, Claudius, et al.
Publicado: (2021)

Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
por: Benning, Louise, et al.
Publicado: (2022)

Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
por: Benning, Louise, et al.
Publicado: (2022)

Living Donor Kidney Transplantation in Patients With Donor-Specific HLA Antibodies After Desensitization With Immunoadsorption
por: Kälble, Florian, et al.
Publicado: (2021)

Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
por: Benning, Louise, et al.
Publicado: (2021)

Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients
por: Benning, Louise, et al.
Publicado: (2022)

Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2
por: Speer, Claudius, et al.
Publicado: (2021)

Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes
por: Nusshag, Christian, et al.
Publicado: (2020)

Humoral response to SARS-CoV-2 mRNA vaccination in previous non-responder kidney transplant recipients after short-term withdrawal of mycophenolic acid
por: Benning, Louise, et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
por: Benning, Louise, et al.
Publicado: (2023)

Plasma exchange in critically ill COVID-19 patients
por: Morath, Christian, et al.
Publicado: (2020)

Follicular Helper T Cells in Systemic Lupus Erythematosus
por: Kim, Sun Jung, et al.
Publicado: (2018)

Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study
por: Nusshag, Christian, et al.
Publicado: (2019)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
por: Chen, Yi-Chieh, et al.
Publicado: (2023)

Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial
por: Morath, Christian, et al.
Publicado: (2022)

Liver-Support Therapies in Critical Illness—A Comparative Analysis of Procedural Characteristics and Safety
por: Göth, Daniel, et al.
Publicado: (2023)

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
por: Benning, Louise, et al.
Publicado: (2022)

T Helper 2-Associated Immunity in the Pathogenesis of Systemic Lupus Erythematosus
por: Ko, Haeun, et al.
Publicado: (2022)

suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
por: Nusshag, Christian, et al.
Publicado: (2023)

Brain paracoccidioidomycosis in an immunosuppressed patient with systemic lupus erythematosus
por: Kamer, Carolina, et al.
Publicado: (2021)

Dilemma of immunosuppression and infection risk in systemic lupus erythematosus
por: He, Jing, et al.
Publicado: (2023)

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus
por: Bonilla-Abadía, Fabio, et al.
Publicado: (2014)

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study
por: Lorenz, Hanns-Martin, et al.
Publicado: (2011)

T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus
por: Yang, Xue, et al.
Publicado: (2014)

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus
por: Jin, Xin, et al.
Publicado: (2022)

Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience
por: Nusshag, Christian, et al.
Publicado: (2021)

T Helper Cell Infiltration in Osteoarthritis-Related Knee Pain and Disability
por: Nees, Timo Albert, et al.
Publicado: (2020)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Targeting of Janus Kinases Limits Pro-Inflammatory but Also Immunosuppressive Circuits in the Crosstalk between Synovial Fibroblasts and Lymphocytes
por: Yao, Nina, et al.
Publicado: (2021)

Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus
por: Northcott, Melissa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4uk4sd8kr7nuvlre5f73kajrpi